GLP-1 Patches Don't Exist Yet — Here's What the Side Effect Data Would Look Like
Transdermal delivery could reshape GLP-1 side effects by changing absorption kinetics.
Tobias Wrenfield
Section
4 stories in Features.
Transdermal delivery could reshape GLP-1 side effects by changing absorption kinetics.
Degradation and poor permeability make the lungs a dead end for GLP-1 drugs.
The physics of peptide size and skin chemistry make passive delivery impossible.
Lung delivery of insulin revealed what any peptide must overcome to reach the bloodstream.